🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
CCOP - Cedar Rapids Oncology Project
Start Date
1996-01
Trial ID
NCT00002716
Treatments Being Tested
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This phase I/II clinical trial is studying the side effects and best dose o...
Status
Terminated
Location
Lucile Packard Children's Hospital Stanford University
Start Date
2010-03
Trial ID
NCT01088763
This phase II trial studies how well daratumumab, azacitidine, and dexameth...
Status
Terminated
Location
University of California, San Francisco
Start Date
2020-11-30
Trial ID
NCT04407442
Treatments Being Tested
The primary purpose of this study is: 1. To compare dexmedetomidine with f...
Status
Completed
Location
Children's National Medical Center
Start Date
2005-01
Trial ID
NCT00654511
Treatments Being Tested
This phase IB trial studies the feasibility of using a functional laborator...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-13
Trial ID
NCT02779283
Treatments Being Tested
This phase II trial studies how well abatacept, ixazomib citrate, and dexam...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2018-09-11
Trial ID
NCT03457142
Treatments Being Tested
This is a study of pembrolizumab (MK-3475) in combination with lenalidomide...
Status
Terminated
Location
Multiple Locations
Start Date
2014-02-14
Trial ID
NCT02036502
Treatments Being Tested
The purpose of this study is to evaluate the effects of the addition of dar...
Status
Completed
Location
Antwerpen
Start Date
2017-06-14
Trial ID
NCT03180736
Treatments Being Tested
The purpose of phase 1 part in this study was to determine the maximum tole...
Status
Completed
Location
Site JP81037
Start Date
2015-02-26
Trial ID
NCT02310321
Treatments Being Tested